SlideShare uma empresa Scribd logo
1 de 27
EU Telematics Hans-Georg Wagner European Medicines Agency 05/26/09 Dubrovnik, Croatia, 22-27 May 2007
Objectives ,[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007
Overview ,[object Object],[object Object],[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007
Introduction ,[object Object],[object Object],[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007
Authorisation of Pharmaceuticals in the EU 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  ,[object Object],[object Object],[object Object],MUST CAN Centralised AP DCP   MRP   NAP
Centralised Authorisation Procedure - EMEA 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  The EMEA is responsible for the evaluation and supervision of medicines for human and veterinary use in the European Union.
The Regulatory Life of a Medicinal Product 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  CT Application CT  Registration R&D Clinical Trials Application Evaluation Authorisation Post Marketing Scientific Advice Safety Monitoring AE Reporting NAP DCP/MRP CAP Application Safety Monitoring AE Reporting Risk Management Safety Monitoring AE Reporting Risk Management GMP
Matching IT Systems at EU Level 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  CT  Registration R&D Clinical Trials Application Evaluation Authorisation Post Marketing Scientific Advice Safety Monitoring AE Reporting CAP Application Safety Monitoring AE Reporting Risk Management GMP EudraCT EudraGMP EudraVigilance EudraVigilance E-Subm.
EudraVigilance (1) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Adverse Event What happened? Which medicinal  product? Which patient? Concomitant drugs? Active ingredients Route of Administration Pharmaceutical form
EudraVigilance (2) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Adverse Event represent Agreed Data Model ‘ E2B’ Valid Values Valid Values Valid Values Dictionaries of controlled terms/codes ICSR SUSAR
EudraVigilance (3) ,[object Object],[object Object],[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007  ‘ E2B’
EudraVigilance (4) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Agreed Data Model ICSR HUMAN ICSR VET SUSAR HUMAN MedDRA EVMPD EV USERS EV CLIENT AXWAY EV WEB TRADER AXWAY CENTRAL GATEWAY DWH BI SE
EudraVigilance (5) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Agreed Data Model EVPM EVCTM EVMPD Prod. SUSAR ICSR Gateway ETL BI MSTR STATS SAS Reports Reports Data Cleaning Duplicate Detection EVIDS
EudraVigilance - Issues ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007  ‘ E2B’
EudraCT (1) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Protocol? Which  Investigational MP? Sites? Sponsor? Active ingredients Route of Administration Pharmaceutical form Strength Clinical  Trial Paediatric? Unique ID?
EudraCT (2) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Sponsor National Competent  Authority Ethics Committee EudraCT Public Site Collect EudraCT Number Download Application Form Submit Application EudraCT Secure Site EudraCT Application EudraCT Repository Register Clinical Trial
EudraCT (3) ,[object Object],[object Object],[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007  ‘ E2B’
EudraCT - Issues ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007  ‘ E2B’
EudraPharm (1) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Regulatory data (MAH, dates, procedure…) Excipients Names, Codes Active ingredients Route of Administration Pharmaceutical form Strength Presentations Medicinal Product Paediatric? Unique Product ID? LBL PIL SPC
EudraPharm (2) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Structured Data Medicinal Product LBL PIL SPC Relational DB Text Repository Public Site Web Services
EudraPharm (3) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  CAP (400) 23+1L DCP MRP (4000) N+1L NAP (400000) 1(+1)L EudraPharm All products All languages
EudraPharm (4) ,[object Object],[object Object],[object Object],[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007  ‘ E2B’
EudraPharm - Issues ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007  ‘ E2B’
EudraGMP (1) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Medicinal Product GMP Inspectorates Member States Inspection Certificate Manufacturing Sites 1:n GMP  Inspection Manufacturing Authorisation GMP Inspectorates MRA States Inspection Certificate GMP  Inspection Negative Outcome Product Alert EudraGMP Database
EudraGMP (2) ,[object Object],[object Object],[object Object],[object Object],[object Object],05/26/09 Dubrovnik, Croatia, 22-27 May 2007  ‘ E2B’
05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Eudra GMP Eudra CT Eudra Vig. Eudra pharm e Subm. Reference Data Model EU Telematics Controlled Terminology EudraDataWarehouse EudraServices EudraNet, EudraLink, Web Services, SSO EudraPortal
05/26/09 Dubrovnik, Croatia, 22-27 May 2007  Hans-Georg Wagner EMEA Communications and Networking [email_address]

Mais conteúdo relacionado

Mais procurados

Point of care testing market and forecast to 2016 global analysis
Point of care testing market and forecast to 2016 global analysisPoint of care testing market and forecast to 2016 global analysis
Point of care testing market and forecast to 2016 global analysis
Renub Research
 
PDA for EBM
PDA for EBMPDA for EBM
PDA for EBM
zalabani
 
Linking Genomic and Clinical Data: The HVPA-BioGrid Experience
Linking Genomic and Clinical Data: The HVPA-BioGrid ExperienceLinking Genomic and Clinical Data: The HVPA-BioGrid Experience
Linking Genomic and Clinical Data: The HVPA-BioGrid Experience
Human Variome Project
 

Mais procurados (15)

2018 Lunevicius LGI bleeding_Klaipeda LT
2018 Lunevicius LGI bleeding_Klaipeda LT2018 Lunevicius LGI bleeding_Klaipeda LT
2018 Lunevicius LGI bleeding_Klaipeda LT
 
Infographic genomic medicine
Infographic genomic medicineInfographic genomic medicine
Infographic genomic medicine
 
Point of care testing market and forecast to 2016 global analysis
Point of care testing market and forecast to 2016 global analysisPoint of care testing market and forecast to 2016 global analysis
Point of care testing market and forecast to 2016 global analysis
 
Trends in the Adoption of Robotic Surgery for Common Surgical Procedures
Trends in the Adoption of Robotic Surgery for Common Surgical ProceduresTrends in the Adoption of Robotic Surgery for Common Surgical Procedures
Trends in the Adoption of Robotic Surgery for Common Surgical Procedures
 
Cell & Gene Therapy Preclinical Development Solutions
Cell & Gene Therapy Preclinical Development SolutionsCell & Gene Therapy Preclinical Development Solutions
Cell & Gene Therapy Preclinical Development Solutions
 
ECPC involvement in research
ECPC involvement in researchECPC involvement in research
ECPC involvement in research
 
Understanding how the eu clinical trials directive could have a feedback impa...
Understanding how the eu clinical trials directive could have a feedback impa...Understanding how the eu clinical trials directive could have a feedback impa...
Understanding how the eu clinical trials directive could have a feedback impa...
 
PDA for EBM
PDA for EBMPDA for EBM
PDA for EBM
 
2017 july-august - EuroLabNews
2017 july-august - EuroLabNews2017 july-august - EuroLabNews
2017 july-august - EuroLabNews
 
Knowledge Engineering from Big Data in Oncology
Knowledge Engineering from Big Data in OncologyKnowledge Engineering from Big Data in Oncology
Knowledge Engineering from Big Data in Oncology
 
Insights Webinar - Regulations Recap
Insights Webinar - Regulations RecapInsights Webinar - Regulations Recap
Insights Webinar - Regulations Recap
 
Assignment 3
Assignment 3Assignment 3
Assignment 3
 
1435 jerome coffey nhc
1435 jerome coffey nhc1435 jerome coffey nhc
1435 jerome coffey nhc
 
Linking Genomic and Clinical Data: The HVPA-BioGrid Experience
Linking Genomic and Clinical Data: The HVPA-BioGrid ExperienceLinking Genomic and Clinical Data: The HVPA-BioGrid Experience
Linking Genomic and Clinical Data: The HVPA-BioGrid Experience
 
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, InvestmentPoint of Care Diagnostics: Revenue Growth, New Entrants, Investment
Point of Care Diagnostics: Revenue Growth, New Entrants, Investment
 

Destaque

Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section
Nitin Kadam
 

Destaque (12)

Unused pharmaceuticals: where do they end up?
Unused pharmaceuticals: where do they end up?Unused pharmaceuticals: where do they end up?
Unused pharmaceuticals: where do they end up?
 
PromoZub
PromoZubPromoZub
PromoZub
 
Content Management in the Pharmaceutical Industry ©RIL
Content Management in the Pharmaceutical Industry ©RILContent Management in the Pharmaceutical Industry ©RIL
Content Management in the Pharmaceutical Industry ©RIL
 
Extempore for pharmaceutical patners 2015
Extempore for pharmaceutical patners 2015Extempore for pharmaceutical patners 2015
Extempore for pharmaceutical patners 2015
 
2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...
2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...
2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...
 
How sap can help pharmaceutical companies
How sap can help pharmaceutical companiesHow sap can help pharmaceutical companies
How sap can help pharmaceutical companies
 
SAP in Pharmaceutical Industry
SAP in Pharmaceutical IndustrySAP in Pharmaceutical Industry
SAP in Pharmaceutical Industry
 
Cross Cultural Communication , Know about turkey
Cross Cultural Communication , Know about turkeyCross Cultural Communication , Know about turkey
Cross Cultural Communication , Know about turkey
 
Step by Step process of Manufacturing of Pharmaceutical Medicine
Step by Step process of Manufacturing of Pharmaceutical MedicineStep by Step process of Manufacturing of Pharmaceutical Medicine
Step by Step process of Manufacturing of Pharmaceutical Medicine
 
Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section Layout of Tablet Manufacturing Section
Layout of Tablet Manufacturing Section
 
Pharmaceutical industry and unit process
Pharmaceutical industry and unit processPharmaceutical industry and unit process
Pharmaceutical industry and unit process
 
Tablet manufacturing process created by Asadulla Mulla
Tablet manufacturing process created by Asadulla MullaTablet manufacturing process created by Asadulla Mulla
Tablet manufacturing process created by Asadulla Mulla
 

Semelhante a EU telematics in the regulation of pharmaceuticals

How to identify radiology productivity bottlenecks?
How to identify radiology productivity bottlenecks?How to identify radiology productivity bottlenecks?
How to identify radiology productivity bottlenecks?
Sergey Morozov, MD, PhD, MPH
 
Let's talk causality attribution: Current practices and path forward
Let's talk causality attribution: Current practices and path forward Let's talk causality attribution: Current practices and path forward
Let's talk causality attribution: Current practices and path forward
Arete-Zoe, LLC
 
2004 10-19 rudi vdv
2004 10-19 rudi vdv2004 10-19 rudi vdv
2004 10-19 rudi vdv
guest3cf4991
 
Software As Device - Frank Maxwell
Software As Device - Frank MaxwellSoftware As Device - Frank Maxwell
Software As Device - Frank Maxwell
healthcareisi
 
Highlights from ExL Pharma's 5th Clinical Data Disclosure Summit
Highlights from ExL Pharma's 5th Clinical Data Disclosure SummitHighlights from ExL Pharma's 5th Clinical Data Disclosure Summit
Highlights from ExL Pharma's 5th Clinical Data Disclosure Summit
ExL Pharma
 
Personalized medicine-genetic-diagnostics-technologies
Personalized medicine-genetic-diagnostics-technologiesPersonalized medicine-genetic-diagnostics-technologies
Personalized medicine-genetic-diagnostics-technologies
cancerdrg
 

Semelhante a EU telematics in the regulation of pharmaceuticals (20)

Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...
Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...
Coming to grips with unfamiliar uncertainties of a new predictive toxicology ...
 
Session 8 david_barton
Session 8 david_bartonSession 8 david_barton
Session 8 david_barton
 
Prosoft Clinical
Prosoft ClinicalProsoft Clinical
Prosoft Clinical
 
How to identify radiology productivity bottlenecks?
How to identify radiology productivity bottlenecks?How to identify radiology productivity bottlenecks?
How to identify radiology productivity bottlenecks?
 
KCR: Cost effectiveness in clinical trials
KCR: Cost effectiveness in clinical trialsKCR: Cost effectiveness in clinical trials
KCR: Cost effectiveness in clinical trials
 
Validating the methodology and the functional criteria of EuroRec Seal - an e...
Validating the methodology and the functional criteria of EuroRec Seal - an e...Validating the methodology and the functional criteria of EuroRec Seal - an e...
Validating the methodology and the functional criteria of EuroRec Seal - an e...
 
Let's talk causality attribution: Current practices and path forward
Let's talk causality attribution: Current practices and path forward Let's talk causality attribution: Current practices and path forward
Let's talk causality attribution: Current practices and path forward
 
2004 10-19 rudi vdv
2004 10-19 rudi vdv2004 10-19 rudi vdv
2004 10-19 rudi vdv
 
Software As Device - Frank Maxwell
Software As Device - Frank MaxwellSoftware As Device - Frank Maxwell
Software As Device - Frank Maxwell
 
Building a link between ectd and xevmpd
Building a link between ectd and xevmpdBuilding a link between ectd and xevmpd
Building a link between ectd and xevmpd
 
Pharmacovigilance evmpd submission
Pharmacovigilance evmpd submissionPharmacovigilance evmpd submission
Pharmacovigilance evmpd submission
 
VITO-ABS offers toxicology and ecotoxicology services
VITO-ABS offers toxicology and ecotoxicology servicesVITO-ABS offers toxicology and ecotoxicology services
VITO-ABS offers toxicology and ecotoxicology services
 
Highlights from ExL Pharma's 5th Clinical Data Disclosure Summit
Highlights from ExL Pharma's 5th Clinical Data Disclosure SummitHighlights from ExL Pharma's 5th Clinical Data Disclosure Summit
Highlights from ExL Pharma's 5th Clinical Data Disclosure Summit
 
The Importance of Developing a Global Regulatory Strategy towards the Goal of...
The Importance of Developing a Global Regulatory Strategy towards the Goal of...The Importance of Developing a Global Regulatory Strategy towards the Goal of...
The Importance of Developing a Global Regulatory Strategy towards the Goal of...
 
Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval
Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval	Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval
Ed Ball - Liverpool City Region SME workshop: Regulatory process and approval
 
PharmaLedger Official Presentation Overview
PharmaLedger Official Presentation OverviewPharmaLedger Official Presentation Overview
PharmaLedger Official Presentation Overview
 
EMA Guidelines for Clinical Trial Management - Pepgra Healthcare
EMA Guidelines for Clinical Trial Management - Pepgra HealthcareEMA Guidelines for Clinical Trial Management - Pepgra Healthcare
EMA Guidelines for Clinical Trial Management - Pepgra Healthcare
 
Corso caltanissetta 08 02-2019
Corso caltanissetta 08 02-2019Corso caltanissetta 08 02-2019
Corso caltanissetta 08 02-2019
 
Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices Clinical Evaluation of Medical Devices
Clinical Evaluation of Medical Devices
 
Personalized medicine-genetic-diagnostics-technologies
Personalized medicine-genetic-diagnostics-technologiesPersonalized medicine-genetic-diagnostics-technologies
Personalized medicine-genetic-diagnostics-technologies
 

Mais de inemet

Mais de inemet (20)

EUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical SciencesEUFEPS and European Initiatives in Pharmaceutical Sciences
EUFEPS and European Initiatives in Pharmaceutical Sciences
 
Legal requirements for generics and abridged products and bioequivalence
Legal requirements for generics and abridged products and bioequivalenceLegal requirements for generics and abridged products and bioequivalence
Legal requirements for generics and abridged products and bioequivalence
 
Significance of BA/BE studies in drug research and evaluation of different as...
Significance of BA/BE studies in drug research and evaluation of different as...Significance of BA/BE studies in drug research and evaluation of different as...
Significance of BA/BE studies in drug research and evaluation of different as...
 
The role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalenceThe role of dissolution in the demonstration of bioequivalence
The role of dissolution in the demonstration of bioequivalence
 
Future trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnologyFuture trends and perspectives in modern pharmaceutical biotechnology
Future trends and perspectives in modern pharmaceutical biotechnology
 
Focussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enoughFocussing on cytotoxic treatment alone is not enough
Focussing on cytotoxic treatment alone is not enough
 
Bioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfallsBioavailability and bioequivalence – problems and pitfalls
Bioavailability and bioequivalence – problems and pitfalls
 
Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?Quo Vadis EU Pharmacy?
Quo Vadis EU Pharmacy?
 
Education - Do we have a choice?
Education - Do we have a choice?Education - Do we have a choice?
Education - Do we have a choice?
 
The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...The truth between the lines – Community pharmacists in improving the health o...
The truth between the lines – Community pharmacists in improving the health o...
 
BY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUEBY HELPING PEOPLE MY DREAM IS BECOMING TRUE
BY HELPING PEOPLE MY DREAM IS BECOMING TRUE
 
POSTGENETICS MEDICINE
POSTGENETICS MEDICINEPOSTGENETICS MEDICINE
POSTGENETICS MEDICINE
 
SHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERSSHARING VISION – TOWARDS BIOMEDICINE PARTNERS
SHARING VISION – TOWARDS BIOMEDICINE PARTNERS
 
Sightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forwardSightseeing Pharmacy practice - The way forward
Sightseeing Pharmacy practice - The way forward
 
Generics and Biogenerics
Generics and BiogenericsGenerics and Biogenerics
Generics and Biogenerics
 
Pharmacovigilance Workshop
Pharmacovigilance WorkshopPharmacovigilance Workshop
Pharmacovigilance Workshop
 
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
ARE WE USING THE RIGHT OUTCOME MEASURE TO ASCERTAIN PATIENT BENEFIT FROM DRUG...
 
Making knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency MapsMaking knowledge matter: The Skills Inventory and the Competency Maps
Making knowledge matter: The Skills Inventory and the Competency Maps
 
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats
 
Pharmacy in croatia - A short overview
Pharmacy in croatia - A short overviewPharmacy in croatia - A short overview
Pharmacy in croatia - A short overview
 

Último

!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
DUBAI (+971)581248768 BUY ABORTION PILLS IN ABU dhabi...Qatar
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
instagramfab782445
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
daisycvs
 
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al MizharAl Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
allensay1
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
Nauman Safdar
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
Abortion pills in Kuwait Cytotec pills in Kuwait
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
ZurliaSoop
 

Último (20)

Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
Horngren’s Cost Accounting A Managerial Emphasis, Canadian 9th edition soluti...
 
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
!~+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUD...
 
Famous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st CenturyFamous Olympic Siblings from the 21st Century
Famous Olympic Siblings from the 21st Century
 
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 MonthsSEO Case Study: How I Increased SEO Traffic & Ranking by 50-60%  in 6 Months
SEO Case Study: How I Increased SEO Traffic & Ranking by 50-60% in 6 Months
 
Cracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' SlideshareCracking the 'Career Pathing' Slideshare
Cracking the 'Career Pathing' Slideshare
 
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in OmanMifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
Mifepristone Available in Muscat +918761049707^^ €€ Buy Abortion Pills in Oman
 
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
Quick Doctor In Kuwait +2773`7758`557 Kuwait Doha Qatar Dubai Abu Dhabi Sharj...
 
Buy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From SeosmmearthBuy Verified TransferWise Accounts From Seosmmearth
Buy Verified TransferWise Accounts From Seosmmearth
 
Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030Over the Top (OTT) Market Size & Growth Outlook 2024-2030
Over the Top (OTT) Market Size & Growth Outlook 2024-2030
 
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al MizharAl Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
Al Mizhar Dubai Escorts +971561403006 Escorts Service In Al Mizhar
 
Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024Marel Q1 2024 Investor Presentation from May 8, 2024
Marel Q1 2024 Investor Presentation from May 8, 2024
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
 
BeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdfBeMetals Investor Presentation_May 3, 2024.pdf
BeMetals Investor Presentation_May 3, 2024.pdf
 
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
 
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabiunwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
unwanted pregnancy Kit [+918133066128] Abortion Pills IN Dubai UAE Abudhabi
 
Power point presentation on enterprise performance management
Power point presentation on enterprise performance managementPower point presentation on enterprise performance management
Power point presentation on enterprise performance management
 
Arti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdfArti Languages Pre Seed Teaser Deck 2024.pdf
Arti Languages Pre Seed Teaser Deck 2024.pdf
 
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All TimeCall 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
Call 7737669865 Vadodara Call Girls Service at your Door Step Available All Time
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
 

EU telematics in the regulation of pharmaceuticals

  • 1. EU Telematics Hans-Georg Wagner European Medicines Agency 05/26/09 Dubrovnik, Croatia, 22-27 May 2007
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Centralised Authorisation Procedure - EMEA 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 The EMEA is responsible for the evaluation and supervision of medicines for human and veterinary use in the European Union.
  • 7. The Regulatory Life of a Medicinal Product 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 CT Application CT Registration R&D Clinical Trials Application Evaluation Authorisation Post Marketing Scientific Advice Safety Monitoring AE Reporting NAP DCP/MRP CAP Application Safety Monitoring AE Reporting Risk Management Safety Monitoring AE Reporting Risk Management GMP
  • 8. Matching IT Systems at EU Level 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 CT Registration R&D Clinical Trials Application Evaluation Authorisation Post Marketing Scientific Advice Safety Monitoring AE Reporting CAP Application Safety Monitoring AE Reporting Risk Management GMP EudraCT EudraGMP EudraVigilance EudraVigilance E-Subm.
  • 9. EudraVigilance (1) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Adverse Event What happened? Which medicinal product? Which patient? Concomitant drugs? Active ingredients Route of Administration Pharmaceutical form
  • 10. EudraVigilance (2) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Adverse Event represent Agreed Data Model ‘ E2B’ Valid Values Valid Values Valid Values Dictionaries of controlled terms/codes ICSR SUSAR
  • 11.
  • 12. EudraVigilance (4) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Agreed Data Model ICSR HUMAN ICSR VET SUSAR HUMAN MedDRA EVMPD EV USERS EV CLIENT AXWAY EV WEB TRADER AXWAY CENTRAL GATEWAY DWH BI SE
  • 13. EudraVigilance (5) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Agreed Data Model EVPM EVCTM EVMPD Prod. SUSAR ICSR Gateway ETL BI MSTR STATS SAS Reports Reports Data Cleaning Duplicate Detection EVIDS
  • 14.
  • 15. EudraCT (1) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Protocol? Which Investigational MP? Sites? Sponsor? Active ingredients Route of Administration Pharmaceutical form Strength Clinical Trial Paediatric? Unique ID?
  • 16. EudraCT (2) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Sponsor National Competent Authority Ethics Committee EudraCT Public Site Collect EudraCT Number Download Application Form Submit Application EudraCT Secure Site EudraCT Application EudraCT Repository Register Clinical Trial
  • 17.
  • 18.
  • 19. EudraPharm (1) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Regulatory data (MAH, dates, procedure…) Excipients Names, Codes Active ingredients Route of Administration Pharmaceutical form Strength Presentations Medicinal Product Paediatric? Unique Product ID? LBL PIL SPC
  • 20. EudraPharm (2) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Structured Data Medicinal Product LBL PIL SPC Relational DB Text Repository Public Site Web Services
  • 21. EudraPharm (3) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 CAP (400) 23+1L DCP MRP (4000) N+1L NAP (400000) 1(+1)L EudraPharm All products All languages
  • 22.
  • 23.
  • 24. EudraGMP (1) 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Medicinal Product GMP Inspectorates Member States Inspection Certificate Manufacturing Sites 1:n GMP Inspection Manufacturing Authorisation GMP Inspectorates MRA States Inspection Certificate GMP Inspection Negative Outcome Product Alert EudraGMP Database
  • 25.
  • 26. 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Eudra GMP Eudra CT Eudra Vig. Eudra pharm e Subm. Reference Data Model EU Telematics Controlled Terminology EudraDataWarehouse EudraServices EudraNet, EudraLink, Web Services, SSO EudraPortal
  • 27. 05/26/09 Dubrovnik, Croatia, 22-27 May 2007 Hans-Georg Wagner EMEA Communications and Networking [email_address]